Edinburgh Research Explorer

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1075-1077
Number of pages3
JournalThorax
Volume68
Issue number11
DOIs
Publication statusPublished - 1 Nov 2013

Abstract

The UK Cystic Fibrosis Gene Therapy Consortium has been working towards clinical gene therapy for patients with cystic fibrosis for several years. We have recently embarked on a large, multi-dose clinical trial of a nonviral, liposome-based formulation powered for the first time to detect clinical benefit. The article describes the details of the protocol.

ID: 7690415